to main content
Portrait of Toms Vengaloor Thomas, MD,  specialist at Kelsey-Seybold Clinic.

Toms Vengaloor Thomas, MD

Welcoming New Patients

Ways to Schedule an Appointment

  • About the Provider
  • Education & Board Certification
  • Professional Associations

Toms Vengaloor Thomas, MD, is a board-certified radiation oncologist who provides individualized radiation therapy for patients with cancer and select noncancerous conditions. He earned his medical degree at Government Medical College in Kottayam, India, in 2012. After relocating to Texas and completing an internship at Texas Health Presbyterian Hospital in Dallas, he completed both a residency and fellowship in Radiation Oncology at the University of Mississippi Medical Center in Jackson. Bilingual in English and Malayalam, Dr. Thomas joined Kelsey-Seybold in October 2026.

Inspired by the experiences of his grandmother and aunt with cancer, Dr. Thomas understands the importance of providing both medical expertise and compassionate support to patients and their families. He cares for patients who need radiation therapy to treat cancer or relieve cancer-related symptoms and has clinical interests in prostate, breast, central nervous system, and gastrointestinal cancers, as well as radiopharmaceutical therapy and low-dose radiation therapy for certain noncancerous conditions. His favorite part of practicing medicine is building connections with patients and their families — finding meaning in helping others feel less overwhelmed, understand their choices, or find relief from symptoms, and celebrate moments of joy.

Philosophy of Care

Dr. Thomas believes in caring for the person, not just the cancer — so he begins by listening, asking and welcoming questions, striving to understand his patients’ concerns and what matters most to them. He strives to provide the same medical expertise, compassion, honesty, and clear communication that he would want for his own family while respecting each patient's individual values and choices.

Joined Kelsey-Seybold: October 2026

Awards & Publications

Awards

  • Educator of the Year, Dept. of Radiation Oncology, UMMC — March 2023
  • AMA National Advocacy Conference Scholarship — February 2021
  • Featured in AMA #RecognizingResidents Campaign — July 2020
  • Travel Grant, American College of Radiation Oncology (ACRO) — 2020 & 2021

Publications

Duggar W, Dulaney C, Mangana S, Roberts P, Michael V, Suggs M, Thomas TV.* Practice patterns of breast radiation therapy in Mississippi: insights and opportunities from a survey among Mississippi radiation oncologists. J Miss State Med Assoc. 2024;65(11/12).

Wang Y, Rahman A, Duggar WN, Thomas TV, Roberts PR, Vijayakumar S, Jiao Z, Bian L, Wang H. A gradient mapping guided explainable deep neural network for extracapsular extension identification in 3D head and neck cancer computed tomography images. Med Phys. 2024;51(3):2007–2019. PMID: 37643447

Wang Y, Duggar WN, Caballero DM, Thomas TV, Adari N, Mundra EK, Wang H. A brain MRI dataset and baseline evaluations for tumor recurrence prediction after Gamma Knife radiotherapy. Sci Data. 2023;10:785. PMID: 37938247. DOI: 10.1038/s41597-023-02683-1

Duggar WN, Roberts PR, Thomas TV, Dulaney C. Building better patient care in Mississippi radiation oncology: why Mississippi needs a collaborative quality initiative. South Med J. 2023;116(5):415–418. PMID:37137476

Leblanc A, Thomas TV, Bouganim N. Chemoradiation for locoregionally advanced laryngeal cancer. Otolaryngol Clin North Am. 2023;56(2):285–293. PMID: 37030941. DOI: 10.1016/j.otc.2022.12.004

Duggar WN, Vengaloor Thomas T, Wang Y, Rahman A, Wang H, Roberts PR, Bian L, Gatewood RT, Vijayakumar S. Preoperative prediction and identification of extracapsular extension in head and neck cancer patients: progress and potential. Cureus. 2023;15(2):e34769. PMID: 36909098. PMCID: PMC10001423

Duggar WN, Weatherall L, Nittala MR, Thomas TV, Mundra EK, Otts J, Woods WC, Yang C, Vijayakumar S. Strategic reduction of package time in head and neck cancer. Adv Radiat Oncol. 2022. PMID: 36407682. PMCID: PMC9667191. DOI: 10.1016/j.adro.2022.101117

Ryckman JM, Thomas TV, Wang M, Wu X, Siva S, Spratt DE, Slotman B, Pal S, Chapin BF, Fitzal F, Soran A, Bex A, Louie AV, Lehrer EJ, Zaorsky NG. Local treatment of the primary tumor for patients with metastatic cancer (PRIME-TX): a meta-analysis. Int J Radiat Oncol Biol Phys. 2022. PMID: 35840112. DOI:10.1016/j.ijrobp.2022.06.095

Palokas M, Christian R, Hinton E, Duhe R, Thomas T, Torres E, Jordan C, Gordy XZ, Sharma M, Gomillia C, Stefanek M, Robinson WR. Barriers and facilitators to cancer clinical trial enrollment and participation among rural populations: a scoping review protocol. JBI Evid Synth. 2022;20(7):1827–1834. PMID: 36164715

Thomas TV, Mathew A. Access, affordability, and sustainability: barriers to high-quality care in a high-income country. Indian J Med Paediatr Oncol. 2022;43(03):285–288.

Hobbies & Interests

Outside of medicine, Dr. Thomas loves spending time with his wife and children, especially when traveling, taking family trips, and exploring new places together. He also enjoys following soccer and cricket and playing pickleball.

Medical School

  • Government Medical College – Kottayam, Kerala, India, 2012

Internship/Residency

  • Radiation Oncology fellowship: University of Mississippi Medical Center – Jackson, MS, 2017, Radiation Oncology residency: University of Mississippi Medical Center – Jackson, MS, 2021

Board Certifications

  • American Board of Radiology - Radiation Oncology
Dr. Thomas is a member of the American Society for Therapeutic Radiation Oncology, American Medical Association, and American College of Radiation Oncology.

Locations

Berthelsen Main Campus

2727 W. Holcombe Blvd.,
Houston, TX 77025

Get Directions 713-442-0000

Bay Area Campus Cancer Center

18833 Gulf Fwy.,
Building C,
Webster, TX 77598

Get Directions 713-442-1081

Accepted Insurance

Data Use: We use cookies and similar tools to make your use of this website easy and to keep it working properly. We may share data about you and how you use the site with third parties, such as analytics and marketing partners. Learn more in our Privacy Policy and Terms of Use. By continuing to use the site, you agree to this.